Weifeng Shang
- Co-authors
- Yali RenYuanyuan LiGang XuShuwang GeJunwu DongWěi LiRui ZengMing Tian
- Topics
- Dialysis and Renal Disease Management (4 papers)COVID-19 Clinical Research Studies (3 papers)Heart Failure Treatment and Management (3 papers)
In The Last Decade
Weifeng Shang
22 papers receiving 585 citations
Peers
Comparison fields: 5 of 83
- Pulmonary and Respiratory Medicine 181
- Infectious Diseases 165
- Nephrology 133
- Oncology 96
- Neurology 86
Countries citing papers authored by Weifeng Shang
This map shows the geographic impact of Weifeng Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Shang more than expected).
Fields of papers citing papers by Weifeng Shang
This network shows the impact of papers produced by Weifeng Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Shang. The network helps show where Weifeng Shang may publish in the future.
Co-authorship network of co-authors of Weifeng Shang
This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Shang. A scholar is included among the top collaborators of Weifeng Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Shang. Weifeng Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 7 | |
| 6 | 14 | |
| 7 | 10 | |
| 8 | 3 | |
| 9 | 9 | |
| 10 | 2 | |
| 11 | 37 | |
| 12 | 37 | |
| 13 | 64 | |
| 14 | 29 | |
| 15 | 35 | |
| 16 | 26 | |
| 17 | 31 | |
| 18 | 36 | |
| 19 | 17 | |
| 20 | 51 |
About Weifeng Shang
Weifeng Shang is a scholar working on Nephrology, Transplantation and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 598 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (4 papers), COVID-19 Clinical Research Studies (3 papers) and Heart Failure Treatment and Management (3 papers). The work is most often cited by research in Nephrology (133 citations), Infectious Diseases (165 citations) and Gastroenterology (41 citations). Weifeng Shang has collaborated with scholars based in China and Germany. Frequent co-authors include Yali Ren, Yuanyuan Li, Gang Xu, Shuwang Ge, Junwu Dong, Wěi Li, Rui Zeng, Ming Tian, Yi Yang and Min Han. Their work appears in journals such as PLoS ONE, Journal of Medical Virology and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.